BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 1102083)

  • 1. The clinical impact of screening and other experimental tumor studies.
    Johnson RK; Goldin A
    Cancer Treat Rev; 1975 Mar; 2(1):1-31. PubMed ID: 1102083
    [No Abstract]   [Full Text] [Related]  

  • 2. [Potentiation of the antitumor action of alkylating compounds by amphotericin B].
    Iaremenko KV; Eremeeva AA; Tereshin IM
    Antibiotiki; 1977; 22(2):153-8. PubMed ID: 404957
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening data from the Cancer Chemotherapy National Service Center screening laboratories. XL. Plant extracts.
    Abbott BJ; Hartwell JL; Leiter J; Perdue RE; Schepartz SA
    Cancer Res; 1967 Mar; 27(3 Pt 2):190-345. PubMed ID: 4289800
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XLI. Plant extracts.
    Abbott BJ; Hartwell JL; Leiter J; Spetzman LA; Schepartz SA
    Cancer Res; 1967 May; 27(5 Pt 2):364-527. PubMed ID: 4290629
    [No Abstract]   [Full Text] [Related]  

  • 5. A modified screening system to select new cytostatic drugs.
    Kraemer HP; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):301-28. PubMed ID: 6383326
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitumor activity of some acylhydrazines.
    Rutner H; Lewin N; Woodbury EC; McBride RJ; Rao KV
    Cancer Chemother Rep; 1974; 58(6):803-10. PubMed ID: 4447923
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening data from the Cancer Chemotherapy National Service Center screening laboratories. XXXIX. Plant extracts.
    Abbott BJ; Hartwell JL; Leiter J; Perdue RE; Price JR; Schepartz SA
    Cancer Res; 1967 Feb; 27(2 Pt 2):1-171. PubMed ID: 4289484
    [No Abstract]   [Full Text] [Related]  

  • 8. Kethoxal bis(thiosemicarbazone). I. Effects against experimental tumors.
    Mihich E; Nichol CA
    Cancer Res; 1965 Oct; 25(9):1410-6. PubMed ID: 5217028
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination therapy: some concepts and results.
    Skipper HE
    Cancer Chemother Rep 2; 1974 Mar; 4(1):137-45. PubMed ID: 4363649
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XXI.
    Leiter J; Abbott BJ; Schepartz SA
    Can Res Suppl; 1964 Dec; ():1093-353. PubMed ID: 5878218
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XV.
    Leiter J; Abbott BJ; Bourke AR; Schepartz SA; Wodinsky I
    Cancer Res; 1963 Sep; 23(8 Pt 2):1483-729. PubMed ID: 5878214
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha-(N)-formylheteroaromatic thiosemicarbazones. Inhibition of tumor-derived ribonucleoside diphosphate reductase and correlation with in vivo antitumor activity.
    French FA; Blanz EJ; Shaddix SC; Brockman RW
    J Med Chem; 1974 Feb; 17(2):172-81. PubMed ID: 4809253
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of AT1727 on growth and metastasis of murine tumours.
    Li XT; Hutchinson GE; Pym BA; Finch M; Hellmann K
    Eur J Cancer Clin Oncol; 1983 Feb; 19(2):283-7. PubMed ID: 6681774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antitumour activity of a series of benzothiophenes.
    Hellmann K; Marshall PG; Stayt S
    Biochem Pharmacol; 1967 Apr; 16(4):681-7. PubMed ID: 6033788
    [No Abstract]   [Full Text] [Related]  

  • 15. Attempted drug-tumor sensitivity matching using diffusion chamber-cultivated cells.
    Mason BH; Cain BF
    Cancer Treat Rep; 1978 Dec; 62(12):2035-43. PubMed ID: 751713
    [No Abstract]   [Full Text] [Related]  

  • 16. Some thoughts on experimental models and their clinical correlations.
    Carter SK
    Eur J Cancer (1965); 1973; 9(11-12):833-41. PubMed ID: 4804310
    [No Abstract]   [Full Text] [Related]  

  • 17. Methanesulfonates: the relationship of structure to antitumor activity.
    Sandberg JS; Wood HB; Engle RR; Venditti JM; Goldin A
    Cancer Chemother Rep 2; 1972 Nov; 3(1):137-229. PubMed ID: 4350012
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antineoplastic activity of antibiotic 1719 from the group of diazo compounds].
    Shorin VA; Averbukh LA; Bazhanov VS; Lepeshkina GN; Grinshteĭn AM
    Antibiotiki; 1972 Aug; 17(8):675-80. PubMed ID: 4678532
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis of potential antineoplastic agents. XV. Some l,4-bisamides of 1,2,3,4-tetrahydroquinoxaline.
    Schuyler P; Popp FD; Noble AC; Alwani DW; Masters BR
    J Med Chem; 1966 Sep; 9(5):704-7. PubMed ID: 6007964
    [No Abstract]   [Full Text] [Related]  

  • 20. Preclinical status of macromomycin at the National Cancer Institute.
    Bono VH; Abraham D
    Recent Results Cancer Res; 1978; 63():113-9. PubMed ID: 705006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.